Date published: 2026-2-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

5-Iodo-Indirubin-3′-monoxime

0.0(0)
Write a reviewAsk a question

Application:
5-Iodo-Indirubin-3′-monoxime is an inhibitor of GSK-3β, CDK-1, and CDK-5
Purity:
≥98%
Molecular Weight:
403.2
Molecular Formula:
C16H10IN3O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

5-Iodo-Indirubin-3′-monoxime is a synthetic derivative of indirubin. This chemical is part of the indirubin family, known for their potent inhibitory activity against various kinases, particularly cyclin-dependent kinases (CDKs) and glycogen synthase kinase-3 (GSK-3). The mechanism of action of 5-Iodo-Indirubin-3′-monoxime involves its interaction with the ATP-binding sites of these kinases. By binding to these sites, it competitively inhibits the kinases′ ability to phosphorylate their respective substrates. This inhibition results in the modulation of various cellular processes controlled by these enzymes, such as cell cycle progression and signal transduction pathways. The addition of the iodine atom at the 5-position on the indirubin molecule enhances its specificity and potency as a kinase inhibitor. In research, 5-Iodo-Indirubin-3′-monoxime has been extensively used to study the regulation of cell cycle and cell division, particularly in cancer cell lines. It has been a valuable tool for dissecting the molecular mechanisms underlying cellular responses to kinase inhibition, especially in understanding how these responses can be manipulated to control cell growth and proliferation.


5-Iodo-Indirubin-3′-monoxime References

  1. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.  |  Hoessel, R., et al. 1999. Nat Cell Biol. 1: 60-7. PMID: 10559866
  2. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?  |  Leclerc, S., et al. 2001. J Biol Chem. 276: 251-60. PMID: 11013232
  3. Indirubin derivative 7-bromoindirubin-3-oxime (7Bio) attenuates Aβ oligomer-induced cognitive impairments in mice  |  Liping Chen, et al. 2017. Frontiers in Molecular Neuroscience. 10: 393.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

5-Iodo-Indirubin-3'-monoxime, 1 mg

sc-221754
1 mg
$108.00